TeraCrystal assisted Icon Bioscience

TeraCrystal assisted Icon Bioscience

TeraCrystal assisted Icon Bioscience, Inc, a USA based ocular delivery company, in characterization of their proprietary Verisome™ delivery platform. The technical data package generated by TeraCrystal’s state-of-the art in situ characterization methodologies successfully support the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA). The project was completed in collaboration with the US based consulting firm, Bryla CMC-Reg Consulting, LLC.

Leave a reply

Your email address will not be published. Required fields are marked *